Bank of America Corporation »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.0M 6.9M 1.17
2024-03-31 $148k 157k 0.94

More positions owned by Bank of America Corporation

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Amazon (AMZN)

View all positions for Bank of America Corporation

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Deerfield Management Company
Aequim Alternative Investments
Lazard Asset Management
BlackRock
Calamos Advisors
Invesco
MacKay Shields
Shenkman Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
SSI Investment Management
Bnp Paribas Arbitrage, Snc
Bank of America Corporation
Franklin Resources

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1